Larvol Delta - BlossomHill-Therapeutics-Doses-Patients-in-the-First-Cohort-of-the-Phase-12-SOLARA-Clinical-Trial-of-BH30643-for-EGFR-and-HER2Mutated-NonSmall-Cell-Lung-Cancer

BH-30643 - BlossomHill Therap

https://www.businesswire.com/news/home/20250122706462/en/BlossomHill-Therapeutics-Doses-Patients-in-the-First-Cohort-of-the-Phase-12-SOLARA-Clinical-Trial-of-BH-30643-for-EGFR--and-HER2-Mutated-Non-Small-Cell-Lung-Cancer

Jan 22, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next